Press Releases

LAKE MARY, Fla., May 14, 2024 /PRNewswire/ -- TurningPoint Healthcare Solutions, a leader in comprehensive condition management, announced today the acquisition of Fairway Health, a pioneering health technology company specializing in AI-powered tools that streamline complex clinical workflows. This strategic move will enable TurningPoint to deploy their industry-leading clinical expertise for greater impact and transform the healthcare experience for providers... (continue reading...)

Portland, OR, May 14, 2024 (GLOBE NEWSWIRE) -- Cayuse, a leader in research administration software solutions, is proud to announce the release of its latest innovation, Cayuse ThreatShield, powered by IPTalons. This cutting-edge service is specifically designed to protect intellectual property and organizational values within research environments, addressing the ever-growing threats of espionage, misappropriation, and international influence risks.What Cayuse... (continue reading...)

The National Institute of Building Sciences Consultative Council's 2024 Moving Forward Report identifies key issues and makes recommendations to policymakers to guide potential solutions

WASHINGTON, May 14, 2024 /PRNewswire/ -- The National Institute of Building Sciences (NIBS) today issued the 2024 Moving Forward Report, a two-part report focused on recommendations to ensure access to clean water and sanitation and to promote housing affordability.

Dieppe, New Brunswick--(Newsfile Corp. - May 14, 2024) - Colibri Resource Corporation (TSXV: CBI) ("Colibri" or the "Company") is pleased to report that the co-owner of its Pilar Gold & Silver Project in Sonora, Mexico, Tocvan Ventures (51% interest) has announced the results from the initial four of fifteen holes drilled to date in the ongoing Phase 4 RC drill program. Hole JES-24-77 was drilled in the 4-T Trend area and is reported to be the longest and highest-grade... (continue reading...)

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds

VANCOUVER, BC / ACCESSWIRE / May 14, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a clinical stage biopharma company pioneering microdosing treatments for mental health conditions today announced that it has signed a non-binding term sheet to out-license a... (continue reading...)